Myxedema coma risk factors

	Myxedema coma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Myxedema coma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Myxedema coma risk factors On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Myxedema coma risk factors All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Myxedema coma risk factors
CDC on Myxedema coma risk factors
Myxedema coma risk factors in the news
Blogs on Myxedema coma risk factors
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Myxedema coma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Common risk factors in the development of myxedema coma include:^[1]^[2]^[3]

↑ Mazonson PD, Williams ML, Cantley LK, Dalldorf FG, Utiger RD, Foster JR (1984). "Myxedema coma during long-term amiodarone therapy". Am. J. Med. 77 (4): 751–4. PMID 6486153.
↑ Kargili A, Turgut FH, Karakurt F, Kasapoglu B, Kanbay M, Akcay A (2010). "A forgotten but important risk factor for severe hyponatremia: myxedema coma". Clinics (Sao Paulo). 65 (4): 447–8. doi:10.1590/S1807-59322010000400015. PMC 2862668. PMID 20454504.
↑ Kwaku MP, Burman KD (2007). "Myxedema coma". J Intensive Care Med. 22 (4): 224–31. doi:10.1177/0885066607301361. PMID 17712058.